Cardiovascular Journal of Africa: Vol 35 No 3 (SEPTEMBER/OCTOBER 2024)

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 35, No 3, September – October 2024 170 AFRICA The European Society of Vascular Surgery guidelines reported that studies have shown a closure rate of 98% in saphenous vein diameters up to 20 mm.30 However, there are studies reporting that a saphenous vein diameter over 8 mm increased the recanalisation rate and that the increased diameter was associated with a longer stump remnant.30 In our study, the esmarch bandage used during the closure of the saphenous veins with NBCA, stopping the blood flow and reducing the venous structure with compression, was associated with agent exposure and decreased phlebitis, recanalisation and ecchymosis rates. Limitations The main limitation of the study is that it was conducted on a limited number of patients based at a single centre. Larger cohort studies are needed. Another important limitation is that the study lacked groups using other techniques, such as EVLA and RFA. With further studies including these groups, the hypothesis needs to be investigated that wrapping with esmarch may be effective by blocking blood flow in the vessel to be treated, and reducing the diameter of the vessel. Conclusion Wrapping the vessel extremity with an esmarch bandage during NBCA ablation of the saphenous veins seemed to both increase the success rate of the procedure and reduce adverse events, such as postoperative ecchymosis and thrombophlebitis. This method could be more successful than other endovenous closure techniques. However, comprehensive data are needed to obtain more detailed and precise data. References 1. Khilnani NM, Grassi CJ, Kundu S, D’Agostino HR, Khan AA, McGraw JK, et al. Cardiovascular Interventional Radiological Society of Europe, American College of Phlebology, and Society of Interventional Radiology Standards of Practice Committees. Multi-society consensus quality improvement guidelines for the treatment of lower-extremity superficial venous insufficiency with endovenous thermal ablation from the Society of Interventional Radiology, Cardiovascular Interventional Radiological Society of Europe, American College of Phlebology and Canadian Interventional Radiology Association. J Vasc Interv Radiol 2010; 21(1): 14–31. 2. 2.Ontario Health (Quality). Nonthermal endovenous procedures for varicose veins: a health technology assessment. Ont Health Technol Assess Ser 2021; 21(8): 1–188. 3. Orhurhu V, Chu R, Xie K, Kamanyi GN, Salisu B, Salisu-Orhurhu M, et al. Management of lower extremity pain from chronic venous insufficiency: a comprehensive review. Cardiol Ther 2021; 10(1): 111–140. 4. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation 2014; 130(4): 333–346. 5. Pan Y, Zhao J, Mei J, Shao M, Zhang J. Comparison of endovenous laser ablation and high ligation and stripping for varicose vein treatment: a meta-analysis. Phlebology 2014; 29(2): 109–119. 6. Nesbitt C, Bedenis R, Bhattacharya V, Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database Syst Rev 2014; 7: CD005624. Update in: Cochrane Database Syst Rev 2021; 8: CD005624. 7. Whing J, Nandhra S, Nesbitt C, Stansby G. Interventions for great saphenous vein incompetence. Cochrane Database Syst Rev 2021; 8(8): CD005624. 8. Mohammadi Tofigh A, Tahmasebi H, Zebarjadi J. Comparing the success rate and side effects of endovenous laser ablation and radiofrequency ablation to treat varicose veins in the lower limbs: a randomized clinical trial. J Lasers Med Sci 2020; 11(Suppl 1): S43–S48. 9. El Kilic H, Bektas N, Bitargil M, Balkaya IA, Demir T, Koramaz I. Longterm outcomes of endovenous laser ablation, n-butyl cyanoacrylate, and radiofrequency ablation for treatment of chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord 2021: S2213–333X(21)00515-1. 10. Gibson K, Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: Initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular 2017; 25(2): 149–156. 11. Karahan O, Yavuz C, Kankilic N, Demirtas S, Tezcan O, Caliskan A, et al. Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency. Blood Coagul Fibrinolysis 2016; 27(6): 684–690. 12. Kim J, Joh JH, Park HC. Effect of saphenous vein diameter and reflux time on stump length after cyanoacrylate closure. Exp Ther Med 2019; 18(3): 1845–1849. 13. Eroglu E, Yasim A. A randomised clinical trial comparing n-butyl cyanoacrylate, radiofrequency ablation and endovenous laser ablation for the treatment of superficial venous incompetence: two year follow up results. Eur J Vasc Endovasc Surg 2018; 56(4): 553–560. 14. Kemaloğlu C. Saphenous vein diameter is a single risk factor for early recanalization after endothermal ablation of incompetent great saphenous vein. Vascular 2019; 27(5): 537–541. 15. Kubat E, Ünal CS, Geldi O, Çetin E, Keskin A. What is the optimal treatment technique for great saphenous vein diameter of ≥ 10mm? Comparison of five different approaches. Acta Chir Belg 2021; 121(2): 94–101. 16. Tekin AI, Tuncer ON, Memetoğlu ME, Arslan Ü, Öztekin A, Yağmur B, et al. Nonthermal, nontumescent endovenous treatment of varicose veins. Ann Vasc Surg 2016; 36: 231–235. 17. Chan YC, Law Y, Cheung GC, Ting AC, Cheng SW. Cyanoacrylate glue used to treat great saphenous reflux: measures of outcome. Phlebology 2017; 32(2): 99–106. 18. Pavlović MD, Schuller-Petrović S, Pichot O, Rabe E, Maurins U, Morrison N, et al. Guidelines of the First International Consensus Conference on Endovenous Thermal Ablation for Varicose Vein Disease – ETAV consensus meeting 2012. Phlebology 2015; 30(4): 257–273. 19. Yang L, Wang X, Wei Z, Zhu C, Liu J, Han Y. The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study. Surgery 2020; 168(5): 909–914. 20. Bendix SD, Peterson EL, Kabbani LS, Weaver MR, Lin JC. Effect of endovenous ablation assessment stratified by great saphenous vein size, gender, clinical severity, and patient-reported outcomes. J Vasc Surg Venous Lymphat Disord 2021; 9(1): 128–136. 21. Sarma N. Guidelines and recommendation on surgery for venous incompetence and leg ulcer. Indian Dermatol Online J 2014; 5(3): 390–395. 22. Fiengo L, Gwozdz A, Tincknell L, Harvey V, Watts T, Black S. VenaSeal closure despite allergic reaction to n-butyl cyanoacrylate. J Vasc Surg Cases Innov Tech 2020; 6(2): 269–271. 23. Bissacco D, Stegher S, Calliari FM, Viani MP. Saphenous vein ablation with a new cyanoacrylate glue device: a systematic review on 1000 cases. Minim Invasive Ther Allied Technol 2019; 28(1): 6–14. 24. Favard N, Moulin M, Fauque P, Bertaut A, Favelier S, Estivalet L, et al. Comparison of three different embolic materials for varicocele emboli-

RkJQdWJsaXNoZXIy NDIzNzc=